Combined treatment of 3-hydroxypyridine-4-one derivatives and green tea extract to induce hepcidin expression in iron-overloaded b-thalassemic mice

被引:0
作者
Supranee Upanan [1 ]
Kanjana Pangjit [2 ]
Chairat Uthaipibull [3 ]
Suthat Fucharoen [4 ]
Andrew T.Mc Kie [5 ]
Somdet Srichairatanakool [1 ]
机构
[1] Department of Biochemistry, Faculty of Medicine, Chiang Mai University
[2] College of Medicine and Public Health, Ubon Ratchathani University
[3] National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency,Thailand Science Park
[4] Thalassemia Research Center, Institute of Molecular Biosciences, Mahidol University, Salaya Campus
[5] Division of Diabetes and Nutritional Sciences, School of Medicine, King's College London
关键词
Thalassemia; Iron overload; Hepcidin; Iron chelator; Green tea; Hydroxypyridinone;
D O I
暂无
中图分类号
R556.61 [];
学科分类号
1002 ; 100201 ;
摘要
Objective:To evaluate the efficacy of deferiprone(DFP),1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one(CM1)or green tea extract(GTE)in enhancing expression of hepatic hepcidin1(Hamp1)m RNA and relieving iron overload in b-globin knockout thalassemic mice.Methods:The b-globin knockout thalassemic mice were fed with a ferrocenesupplemented diet for 2 months and oral administration of deionized water,DFP(50 mg/kg),CM1(50 mg/kg),GTE(50 mg epigallocatechin 3-gallate equivalent/kg),GTE along with DFP(50 mg/kg),and GTE along with CM1(50 mg/kg)every day for 3months.Levels of hepatic Hamp1 m RNA,plasma non-transferrin bound iron,plasma alanine aminotransferase activity and tissue iron content were determined.Results:All chelation treatments could reduce plasma non-transferrin bound iron concentrations.Additionally,hepatic Hamp1 m RNA expression was significantly upregulated in the mice in a GTE+DFP combined treatment,correlating with a decrease in the plasma alanine aminotransferase activity and tissue iron deposition.Conclusions:The GTE+DFP treatment could ameliorate iron overload and liver oxidative damage in non-transfusion dependent b-thalassemic mice,by chelating toxic iron in plasma and tissues,and increasing hepcidin expression to inhibit duodenal iron absorption and iron release from hepatocytes and macrophages in the spleen.There is probably an advantage in giving GTE with DFP when treating patients with iron overload.
引用
收藏
页码:1010 / 1017
页数:8
相关论文
共 27 条
[1]   Iron-chelating and anti-lipid peroxidation properties of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one(CM1)in longterm iron loading β-thalassemic mice [J].
Kanokwan Kulprachakarn ;
Nittaya Chansiw ;
Kanjana Pangjit ;
Chada Phisalaphong ;
Suthat Fucharoen ;
Robert C.Hider ;
Sineenart Santitherakul ;
Somdet Srichairatanakool .
Asian Pacific Journal of Tropical Biomedicine, 2014, (08) :663-668
[2]  
Synergistic intracellular iron chelation combinations: mechanisms and conditions for optimizing iron mobilization[J] . Evangelia Vlachodimitropoulou Koumoutsea,Maciej Garbowski,John Porter.Br J Haematol . 2015 (6)
[3]  
Update on iron metabolism and molecular perspective of common genetic and acquired disorder, hemochromatosis[J] . Seongseok Yun,Nicole D. Vincelette.Critical Reviews in Oncology / Hematology . 2015 (1)
[4]  
Hepcidin: regulation of the master iron regulator[J] . Gautam Rishi,Daniel?F. Wallace,V.?Nathan Subramaniam.Bioscience Reports . 2015 (3)
[5]  
Characterisation of a novel oral iron chelator: 1‐( N ‐ A cetyl‐6‐ A minohexyl)‐3‐ H ydroxy‐2‐ M ethylpyridin‐4‐one[J] . Kanjana Pangjit,Ratana Banjerdpongchai,Chada Phisalaphong,Suthat Fucharoen,Yuan Yuan Xie,Zi Dong Lu,Robert C. Hider,Somdet Srichairatanakool.J Pharm Pharmacol . 2015 (5)
[6]  
The iron-regulatory hormone hepcidin: A possible therapeutic target?[J] . Luc Rochette,Aurélie Gudjoncik,Charles Guenancia,Marianne Zeller,Yves Cottin,Catherine Vergely.Pharmacology and Therapeutics . 2015
[7]  
Mechanisms of plasma non‐transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients[J] . John B. Porter,Patrick B. Walter,Lynne D. Neumayr,Patricia Evans,Sukhvinder Bansal,Maciej Garbowski,Marcela G. Weyhmiller,Paul R. Harmatz,John C. Wood,Jeffery L. Miller,Colleen Byrnes,Guenter Weiss,Markus Seifert,Regine Grosse,Dagmar Grabowski,Angelica Schmidt,Roland Fischer,Peter Nielsen,Charlotte Niemeyer,Elliott Vichinsky.Br J
[8]   Association of growth differentiation factor 15 (GDF15) polymorphisms with serum GDF15 and ferritin levels in β-thalassemia [J].
Athiyarath, Rekha ;
George, Biju ;
Mathews, Vikram ;
Srivastava, Alok ;
Edison, Eunice S. .
ANNALS OF HEMATOLOGY, 2014, 93 (12) :2093-2095
[9]  
Effect of a novel oral active iron chelator: 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in iron-overloaded and non-overloaded mice[J] . Nittaya Chansiw,Kanjana Pangjit,Chada Phisalaphong,John B. Porter,Patricia Evans,Suthat Fucharoen,Somdet Srichairatanakool.Asian Pacific Journal of Tropical Medicine . 2014
[10]  
mRNA Regulation of Cardiac Iron Transporters and Ferritin Subunits in a Mouse Model of Iron Overload[J] . Casey J. Brewer,Ruth I. Wood,John C. Wood.Experimental Hematology . 2014